Behavioral and quality-of-life outcomes in different service models for methadone maintenance treatment in Vietnam

Harm Reduction Journal

Volumn 13, Issue 1, 2016, Pages

  Tran, Bach Xuan ^a,b   Nguyen, Long Hoang ^a,c   Nong, Vuong Minh ^a   Nguyen, Cuong Tat ^d   Phan, Huong Thu Thi ^e   Latkin, Carl A ^b  

^a HANOI MEDICAL UNIVERSITY   (Viet Nam)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c VIETNAM NATIONAL UNIVERSITY   (Viet Nam)

^d DUY TAN UNIVERSITY   (Viet Nam)

^e MINISTRY OF HEALTH   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE; NARCOTIC AGENT;

ADULT; ANXIETY DISORDER; ARTICLE; CONDOM USE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DRUG USE; FEMALE; HEALTH SERVICE; HUMAN; INTERVIEW; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PAIN; PATIENT CARE; PREVALENCE; QUALITY OF LIFE; RURAL AREA; URBAN AREA; VIET NAM; HEALTH CARE DELIVERY; HIV SEROPOSITIVITY; NONBIOLOGICAL MODEL; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; ORGANIZATION AND MANAGEMENT; PSYCHOLOGY; RURAL POPULATION; SOCIOECONOMICS; TREATMENT OUTCOME; UNSAFE SEX; URBAN POPULATION;

ADULT; CROSS-SECTIONAL STUDIES; DELIVERY OF HEALTH CARE; FEMALE; HIV SEROPOSITIVITY; HUMANS; MALE; METHADONE; MODELS, ORGANIZATIONAL; NARCOTICS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; QUALITY OF LIFE; RURAL POPULATION; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME; UNSAFE SEX; URBAN POPULATION; VIETNAM;

EID: 84956622092     PISSN: None     EISSN: 14777517     Source Type: Journal    
DOI: 10.1186/s12954-016-0091-4     Document Type: Article

References (55)

1. The Commission on AIDS in Asia. Redefining AIDS in Asia: Crafting an effective response. Oxford University Press; 2008; 258. Available at http://www.unaids.org/en/media/unaids/contentassets/dataimport/pub/report/2008/20080326_report_commission_aids_en.pdf. Accessed November 1, 2012.
2. Wu Z, Shi CX, Detels R. Addressing injecting drug use in Asia and Eastern Europe. Curr HIV/AIDS Rep. 2013;10:187-93.
3. Wolfe D. Paradoxes in antiretroviral treatment for injecting drug users: access, adherence and structural barriers in Asia and the former Soviet Union. Int J Drug Policy. 2007;18:246-54.
4. Wodak A. The challenge of HIV spread among and from injecting drug users in Asia. Dev Bull. 2000;42-4.
5. Tran BX, Ohinmaa A, Duong AT, Do NT, Nguyen LT, et al. Cost-effectiveness of methadone maintenance treatment for HIV-positive drug users in Vietnam. AIDS Care. 2012;24:283-90.
6. Tran BX, Ohinmaa A, Duong AT, et al. Changes in drug use are associated with health-related quality of life improvements among methadone maintenance patients with HIV/AIDS. Qual Life Res. 2012;21:613-23.
7. Tran BX, Ohinmaa A, Duong AT, Nguyen LT, Vu PX, Mills S, et al. The cost-effectiveness and budget impact of Vietnam's methadone maintenance treatment programme in HIV prevention and treatment among injection drug users. Glob Public Health. 2012;7:1080-94.
8. Tran BX, Nguyen LT. Impact of methadone maintenance on health utility, health care utilization and expenditure in drug users with HIV/AIDS. Int J Drug Policy. 2013;24:e105-10.
9. Gourevitch MN, Chatterji P, Deb N, Schoenbaum EE, Turner BJ. On-site medical care in methadone maintenance: associations with health care use and expenditures. J Subst Abuse Treat. 2007;32:143-51.
10. Connock M, Juarez-Garcia A, Jowett S, Frew E, Liu Z, Taylor RJ, et al. Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. Health Technol Assess. 2007;11(1-171):iii-iv.
11. Reid G, Sharma M, Higgs P. The long winding road of opioid substitution therapy implementation in South-East Asia: challenges to scale up. J Public Health Res. 2014;3:204.
12. World Health Organization. Proposal for the inclusion of Methadone in the WHO model list of essential medicines. Geneva, Switzerland: 2004.
13. Tran BX, Ohinmaa A, Mills S, Duong AT, Nguyen LT, Jacobs P, et al. Multilevel predictors of concurrent opioid use during methadone maintenance treatment among drug users with HIV/AIDS. PLoS One. 2012;7:e51569.
14. Tran BX. Quality of life outcomes of antiretroviral treatment for HIV/AIDS patients in Vietnam. PLoS One. 2012;7:e41062.
15. Tran BX, Ohinmaa A, Nguyen LT, Nguyen TA, Nguyen TH. Determinants of health-related quality of life in adults living with HIV in Vietnam. AIDS Care. 2011;23:1236-45.
16. Gupta S, Granich R, Suthar AB, Smyth C, Baggaley R, Sculier D, et al. Global policy review of antiretroviral therapy eligibility criteria for treatment and prevention of HIV and tuberculosis in adults, pregnant women, and serodiscordant couples. J Acquir Immune Defic Syndr. 2013;62:e87-97.
17. Iskandar S, Kamal R, De Jong CA. Psychiatric comorbidity in injecting drug users in Asia and Africa. Curr Opin Psychiatry. 2012;25:213-8.
18. Wolfe D, Carrieri MP, Shepard D. Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward. Lancet. 2010;376:355-66.
19. Bruce RD, Lambdin B, Chang O, Masao F, Mbwambo J, Mteza I, et al. Lessons from Tanzania on the integration of HIV and tuberculosis treatments into methadone assisted treatment. Int J Drug Policy. 2014;25:22-5.
20. Tran BX, Ohinmaa A, Duong AT, Nguyen LT, Vu PX, Mills S, et al. Cost-effectiveness of integrating methadone maintenance and antiretroviral treatment for HIV-positive drug users in Vietnam's injection-driven HIV epidemics. Drug Alcohol Depend. 2012;125:260-6.
21. Sheridan J, Goodyear-Smith F, Butler R, Wheeler A, Gohns A. Barriers to, and incentives for, the transfer of opioid-dependent people on methadone maintenance treatment from secondary care to primary health care. Drug Alcohol Rev. 2008;27:178-84.
22. Wang L, Wei X, Wang X, Li J, Li H, Jia W. Long-term effects of methadone maintenance treatment with different psychosocial intervention models. PLoS One. 2014;9:e87931.
23. Reddon H, Milloy MJ, Simo A, Montaner J, Wood E, Kerr T, et al. Methadone maintenance therapy decreases the rate of antiretroviral therapy discontinuation among HIV-positive illicit drug users. AIDS Behav. 2014;18:740-6.
24. Peles E, Schreiber S, Adelson M. Trends in substance abuse and infectious disease over 20 years in a large methadone maintenance treatment (MMT) clinic in Israel. Subst Abus. 2014.
25. Masson CL, Barnett PG, Sees KL, Delucchi KL, Rosen A, Wong W, et al. Cost and cost-effectiveness of standard methadone maintenance treatment compared to enriched 180-day methadone detoxification. Addiction. 2004;99:718-26.
26. Dijkgraaf MG, van der Zanden BP, de Borgie CA, Blanken P, van Ree JM, van den Brink W, et al. Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroin addicts in two randomised trials. BMJ. 2005;330:1297.
27. Vanagas G, Padaiga Z, Bagdonas E. Cost-utility analysis of methadone maintenance treatment: a methodological approach. Subst Use Misuse. 2006;41:87-101.
28. Afriandi I, Siregar AY, Meheus F, Hidayat T, van der Ven A, van Crevel R, et al. Costs of hospital-based methadone maintenance treatment in HIV/AIDS control among injecting drug users in Indonesia. Health Policy. 2010;95:69-73.
29. Tran BX, Ohinmaa A, Duong AT, Nguyen LT, Vu PX, Mills S, et al. The cost-effectiveness and budget impact of Vietnam's methadone maintenance treatment programme in HIV prevention and treatment among injection drug users. Glob Public Health. 2012;7:1080-94.
30. Lambdin BH, Mbwambo JK, Josiah RM, Bruce RD. Service integration: opportunities to expand access to antiretroviral therapy for people who inject drugs in Tanzania. J Int AIDS Soc. 2015;18:19936.
31. Kinahan JC, Surah S, Keating S, Bergin C, Mulcahy F, Lyons F, et al. Effect of integrating HIV and addiction care for non-engaging HIV-infected opiate-dependent patients. Ir J Med Sci. 2015.
32. Guerrero EG, Aarons GA, Palinkas LA. Organizational capacity for service integration in community-based addiction health services. Am J Public Health. 2014;104:e40-7.
33. Tran BX. Willingness to pay for methadone maintenance treatment in Vietnamese epicentres of injection-drug-driven HIV infection. Bull World Health Organ. 2013;91:475-82.
34. Nguyen TT, Nguyen LT, Pham MD, Vu HH, Mulvey KP. Methadone maintenance therapy in Vietnam: an overview and scaling-up plan. Adv Prev Med. 2012;2012:732484.
35. Tran BX, Nguyen LH, Phan HT, Nguyen LK, Latkin CA. Preference of methadone maintenance patients for the integrative and decentralized service delivery models in Vietnam. Harm Reduct J. 2015;12:29.
36. Tran BX, Nguyen LH, Phan HT, Latkin CA. Patient satisfaction with methadone maintenance treatment in vietnam: a comparison of different integrative-service delivery models. PLoS One. 2015;10:e0142644.
37. Tran BX, Van Hoang M, Nguyen HD. Factors associated with job satisfaction among commune health workers: implications for human resource policies. Glob Health Action. 2013;6:1-6.
38. Tran BX, Ohinmaa A, Nguyen LT. Quality of life profile and psychometric properties of the EQ-5D-5L in HIV/AIDS patients. Health Qual Life Outcomes. 2012;10:132.
39. Tran B, Nguyen L, Ohinmaa A, Maher R, Nong V, Latkin CA. et al. Longitudinal and cross sectional assessments of health utility in adults with HIV/AIDS: a systematic review and meta-analysis. BMC Health Serv Res. 2015;15:7.
40. Tran BX, Nong VM, Maher RM, Nguyen PK, Luu HN. A systematic review of scope and quality of health economic evaluation studies in Vietnam. PLoS One. 2014;9:e103825.
41. George S. Review: methadone increases retention and reduces heroin use compared with non-pharmacological maintenance. Evid Based Ment Health. 2010;13:26.
42. Nguyen NT, Tran BX, Hwang LY, Markham CM, Swartz MD, Vidrine JI, et al. Motivation to quit smoking among HIV-positive smokers in Vietnam. BMC Public Health. 2015;15:326.
43. Tran BX, Nguyen LH, Phan HT, Nguyen LK, Latkin CA. Preference of methadone maintenance patients for the integrative and decentralized service delivery models in Vietnam. Harm Reduct J. 2015;12:29.
44. Harris Jr KA, Arnsten JH, Litwin AH. Successful integration of hepatitis C evaluation and treatment services with methadone maintenance. J Addict Med. 2010;4:20-6.
45. Palepu A, Tyndall MW, Joy R, Kerr T, Wood E, Press N, et al. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy. Drug Alcohol Depend. 2006;84:188-94.
46. Herman M, Gourevitch MN. Integrating primary care and methadone maintenance treatment: implementation issues. J Addict Dis. 1997;16:91-102.
47. Tran BX, Duong AT, Nguyen LT, Hwang J, Nguyen BT, Nguyen QT, et al. Financial burden of health care for HIV/AIDS patients in Vietnam. Trop Med Int Health. 2013;18:212-8.
48. Tran BX, Nguyen NP. Patient satisfaction with HIV/AIDS care and treatment in the decentralization of services delivery in Vietnam. PLoS One. 2012;7:e46680.
49. Tran BX, Nguyen LT, Nguyen NH, Hoang QV, Hwang J. Determinants of antiretroviral treatment adherence among HIV/AIDS patients: a multisite study. Glob Health Action. 2013;6:19570.
50. Tran BX, Ohinmaa A, Nguyen LT, Oosterhoff P, Vu PX, Vu TV, et al. Gender differences in quality of life outcomes of HIV/AIDS treatment in the latent feminization of HIV epidemics in Vietnam. AIDS Care. 2012;24:1187-96.
51. Nguyen LH, Tran BX, Nguyen NP, Phan HT, Bui TT, Latkin CA, et al. Mobilization for HIV Voluntary Counseling and Testing Services in Vietnam: clients' risk behaviors, attitudes and willingness to pay. AIDS Behav. 2015.
52. Mykhalovskiy E, Patten S, Sanders C, Bailey M, Taylor D. Conceptualizing the integration of HIV treatment and prevention: findings from a process evaluation of a community-based, national capacity-building intervention. Int J Public Health. 2009;54:133-41.
53. Brienza RS, Stein MD, Chen M, Gogineni A, Sobota M, Maksad J, et al. Depression among needle exchange program and methadone maintenance clients. J Subst Abuse Treat. 2000;18:331-7.
54. Steward WT, Chandy S, Singh G, Panicker ST, Osmand TA, Heylen E, et al. Depression is not an inevitable outcome of disclosure avoidance: HIV stigma and mental health in a cohort of HIV-infected individuals from Southern India. Psychol Health Med. 2011;16:74-85.
55. Lovejoy TI, Heckman TG. Depression moderates treatment efficacy of an HIV secondary-prevention intervention for HIV-positive late middle-age and older adults. Behav Med. 2014;40:124-33.